FACT-8D | EQ-5D-5L crosswalk | EQ-5D-5L EVS | ||||
---|---|---|---|---|---|---|
Mean (SD) | P value | Mean (SD) | P value | Mean (SD) | P value | |
Baseline lymphoma symptoms | 0.02 | < .0001 | < .0001 | |||
No (N = 117) | 0.69 (0.18) | 0.81 (0.21) | 0.87 (0.16) | |||
Yes (N = 133) | 0.63 (0.28) | 0.67 (0.22) | 0.75 (0.21) | |||
Presence lymphoma B symptomsa | < 0.01 | < 0.001 | < 0.001 | |||
No symptoms (N = 186) | 0.68 (0.20) | 0.77 (0.20) | 0.84 (0.16) | |||
One or more symptoms present (N = 64) | 0.60 (0.32) | 0.63 (0.28) | 0.71 (0.26) | |||
Other MCL-related symptoms | 0.10 | <.0001 | < .0001 | |||
No (N = 140) | 0.67 (0.22) | 0.79 (0.21) | 0.85 (0.17) | |||
Yes (N = 110) | 0.63 (0.27) | 0.66 (0.24) | 0.74 (0.22) | |||
ECOGb | < .0001 | < .0001 | < .0001 | |||
0 (N = 117) | 0.74 (0.22) | 0.82 (0.18) | 0.88 (0.15) | |||
1(N = 130) | 0.58 (0.25) | 0.66 (0.23) | 0.74 (0.21) | |||
MIPI | 0.21 | < 0.001 | 0.001 | |||
High Risk (N = 53) | 0.61 (0.27) | 0.63 (0.28) | 0.72 (0.26) | |||
Intermediate (N = 118) | 0.66 (0.24) | 0.75 (0.18) | 0.82 (0.16) | |||
Low Risk (N = 79) | 0.68 (0.23) | 0.78 (0.23) | 0.84 (0.19) | |||
HgB | 0.14 | < 0.001 | < 0.001 | |||
HGB < 130 g/L (N = 137) | 0.60 (0.27) | 0.69 (0.24) | 0.77 (0.22) | |||
HGB > =130 g/L (N = 113) | 0.64 (0.20) | 0.79 (0.19) | 0.85 (0.16) | |||
Previous lines of therapy | 0.43 | 0.35 | 0.35 | |||
1 (N = 98) | 0.68 (0.24) | 0.74 (0.23) | 0.81 (0.19) | |||
2 (N = 69) | 0.64 (0.24) | 0.75 (0.23) | 0.82 (0.18) | |||
≥3 (N = 83) | 0.64 (0.25) | 0.70 (0.23) | 0.78 (0.22) |